Chengdu Kanghua Biological Products (300841.SZ) Earnings Analysis
Chengdu Kanghua Biological Products (300841.SZ) next reports earnings on 2026-08-18. Trailing P/E 25.98.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 300841.SZ next report earnings?
| Next earnings date | 2026-08-18 |
|---|---|
| Consensus EPS estimate | n/a |
| Revenue estimate | n/a |
300841.SZ earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-04-21 | 0.21 CNY | n/a | n/a | n/a |
| 2026-04-20 | 0.24 CNY | n/a | n/a | n/a |
| 2025-04-18 | -0.05544 CNY | n/a | n/a | n/a |
| 2024-10-28 | 0.765 CNY | n/a | n/a | n/a |
| 2024-08-16 | 1.19 CNY | n/a | n/a | n/a |
300841.SZ valuation and analyst view
| Trailing P/E | 25.98 |
|---|---|
| Trailing EPS | 1.744 CNY |
| Price / book | 1.65 |
| Dividend yield | 1.11% |
| Market cap | 5.85B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Chengdu Kanghua Biological Products (300841.SZ)'s next earnings date?
Chengdu Kanghua Biological Products is next scheduled to report on 2026-08-18.
Did 300841.SZ beat earnings last quarter?
Consensus estimate data was not available for 300841.SZ's 2026-04-21 report.
What is 300841.SZ's current P/E ratio and EPS?
300841.SZ trades at a trailing P/E of 25.98 on trailing EPS of 1.7436422693973836 CNY.
What do analysts rate 300841.SZ?
300841.SZ has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.